Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide

Current therapies for childhood T-cell acute lymphoblastic leukemia have increased survival rates to above 85% in developed countries. Unfortunately, some patients fail to respond to therapy and many suffer from serious side effects, highlighting the need to investigate other agents to treat this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ede, Benjamin C., Asmaro, Rafal R, Moppett, John P., Diamanti, Paraskevi, Blair, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119138/
https://www.ncbi.nlm.nih.gov/pubmed/29773592
http://dx.doi.org/10.3324/haematol.2017.186700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119138/
https://www.ncbi.nlm.nih.gov/pubmed/29773592
http://dx.doi.org/10.3324/haematol.2017.186700

Ejemplares similares